海外行/凝心聚力,康體生命美國波士頓分公司正式成立
為了實現(xiàn)加速響應(yīng)客戶需求、“零距離”技術(shù)服務(wù)、無障礙溝通、縮短交付時間等目的,康體生命建立了一支本地化專業(yè)團隊,并整合、優(yōu)化當(dāng)?shù)刭Y源,為客戶提供納米抗體和GPCR靶點膜蛋白的技術(shù)開發(fā)方案。同時,分公司與當(dāng)?shù)囟鄠€合作伙伴建立深度協(xié)作關(guān)系,不斷開拓北美市場??刁w生命美國分公司負責(zé)人Mr.Du表示:“美國團隊能夠為北美乃至全球客戶提供優(yōu)質(zhì)、可靠、誠信、高效的GPCR納米抗體定制研發(fā)及功能驗證一站式解決方案平臺。
In order to achieve the purpose of faster response to customer needs, “zero distance” technical services, barrier-free communication. And shortening delivery time, AlpaLifeB has established a local & professional team. “The U.S. team can offer the worldwide market with high-quality products, realizable services, and efficient one-stop nanobody discovery platform. We are dedicated to support novel nanobody/VHH and GPCR-targeted drug development.” Said by Mr.Du, head of the AlpaLifeB Inc.